Temat: Interesujący webcast

Interesujący webcast, sczególnie dla tych zainteresowanych ‘późnymi fazami’:

Inclusion of $1.1B in the Obama Stimulus Plan to support comparative effectiveness research of drugs, medical devices, surgical procedures and other treatments, is a clear indication of the US Government’s priority to obtain value in healthcare dollar spending. As it gains traction among policymakers, and as the Federal Government continues to increase its role as the largest direct payer for drugs, biologics, devices and diagnostics, we expect regulators to demand such data for new products demonstrating greater benefits over existing products.

Now more than ever, companies need to address value and price in their product development and lifecycle strategies, for products currently in development and for those already commercialized. This calls for a highly efficient and effective approach that recognizes the increasing role that public and private payers play as the gate keepers to patient access and product success.
Our expert panel will review case studies and provide key insights as to the potential future requirements for comparative effectiveness, the opportunities and challenges they pose, and strategies to address.

Informacja o webcascie ze strony:

http://appliedclinicaltrialsonline.findpharma.com/appl...

Ps. Z jakich podcastów oprócz PharmaVOICE korzystacie 'służbowo' ?